Volitionrx Ltd.

Medical Devices • Healthcare • Henderson, NV, United States • VNRX (ASE)

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is based in Henderson, Nevada.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Other Medical Devices Companies

View All →

Abbott Laboratories

$218.91B market cap

Boston Scientific Corp.

Edwards Lifesciences Corp.

$51.04B market cap

Dexcom Inc.

$26.50B market cap

Frequently Asked Questions

Has VOLITIONRX LTD had layoffs?

No layoff events have been recorded for VOLITIONRX LTD in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does VOLITIONRX LTD have?

VOLITIONRX LTD has approximately 75 employees.

What industry is VOLITIONRX LTD in?

VOLITIONRX LTD operates in the Medical Devices industry, within the Healthcare sector.

Is VOLITIONRX LTD a publicly traded company?

Yes, VOLITIONRX LTD is publicly traded under the ticker symbol VNRX on the ASE. The company has a market capitalization of approximately $0.03 billion.

Where is VOLITIONRX LTD headquartered?

VOLITIONRX LTD is headquartered in Henderson, NV, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.